CHUM - Centre hospitalier de l'Universite de Montréal /ID# 269387

Montreal, Quebec H2X 0A9

0 studies enrolling now · 1 studies all time

What they study most

Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer

Studies at this site

• Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer — Running, not enrolling